Table 2 The constituent ratio of different ROR1 expression level under different clinicopathologic variables in 232 lung ADC patients.
From: ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
Clinicopathologic variables | n | ROR1 | χ2 | P-value | |
|---|---|---|---|---|---|
Low | High | ||||
All cases | 232 | 149 | 83 | ||
Age | 0.261 | 0.609 | |||
≤60 | 107 | 67 | 40 | ||
>60 | 123 | 81 | 42 | ||
Unknown | 2 | 1 | 1 | ||
Gender | 4.815 | 0.028* | |||
Female | 109 | 78 | 31 | ||
Male | 123 | 71 | 52 | ||
Tumor Size | 0.939 | 0.332 | |||
≤3 cm | 85 | 58 | 27 | ||
>3 cm | 147 | 91 | 56 | ||
Pathological Grade | 0.039 | 0.843 | |||
I-II | 180 | 115 | 65 | ||
III | 52 | 34 | 18 | ||
AJCC7 Stage | 28.882 | <0.001* | |||
I-II | 136 | 107 | 29 | ||
III-IV | 76 | 32 | 44 | ||
Unknown | 20 | 10 | 10 | ||
Lymph node metastasis | 31.64 | <0.001* | |||
Positive | 110 | 51 | 59 | ||
Negative | 117 | 96 | 21 | ||
Unknown | 5 | 2 | 3 | ||
Histological Type | 1.67 | 0.196 | |||
Pure Adenocarcinoma | 179 | 111 | 68 | ||
Other | 53 | 38 | 15 | ||
